Type | Name | Gene Symbol | Clinical Significance | Chromosome | Start | Stop | Reference Allele | Alternate Allele | Review Status | Other IDs |
---|---|---|---|---|---|---|---|---|---|---|
(GRCh37) | ||||||||||
Indel | NM_058216.3(RAD51C):c.145+2_145+7delinsCTAAG | RAD51C | Likely pathogenic | 17 | 56770151 | 56770156 | TAACGA | CTAAG | criteria provided, single submitter | ClinGen:CA10583601 |
single nucleotide variant | NM_058216.3(RAD51C):c.837+1G>T | RAD51C | Pathogenic/Likely pathogenic | 17 | 56787352 | 56787352 | G | T | criteria provided, multiple submitters, no conflicts | ClinGen:CA10583607 |
Deletion | NM_000059.4(BRCA2):c.2045del (p.Ile682fs) | BRCA2 | Pathogenic | 13 | 32910537 | 32910537 | AT | A | reviewed by expert panel | ClinGen:CA10584440 |
Deletion | NM_000059.4(BRCA2):c.2677del (p.Gln893fs) | BRCA2 | Pathogenic | 13 | 32911168 | 32911168 | TC | T | reviewed by expert panel | ClinGen:CA10584441 |
Deletion | NM_000059.4(BRCA2):c.4594_4598del (p.Val1532fs) | BRCA2 | Pathogenic | 13 | 32913084 | 32913088 | AAAGTT | A | reviewed by expert panel | ClinGen:CA10584446 |
Deletion | NM_000059.4(BRCA2):c.6762del (p.Phe2254fs) | BRCA2 | Pathogenic | 13 | 32915250 | 32915250 | CT | C | reviewed by expert panel | ClinGen:CA10584450 |
single nucleotide variant | NM_000059.4(BRCA2):c.7617+1G>C | BRCA2 | Pathogenic | 13 | 32930747 | 32930747 | G | C | criteria provided, multiple submitters, no conflicts | ClinGen:CA10584451 |
Deletion | NM_007294.4(BRCA1):c.5368del (p.Ser1790fs) | BRCA1 | Pathogenic | 17 | 41201176 | 41201176 | GA | G | reviewed by expert panel | ClinGen:CA10584545 |
Deletion | NM_007294.4(BRCA1):c.5249del (p.Lys1750fs) | BRCA1 | Pathogenic | 17 | 41209097 | 41209097 | CT | C | reviewed by expert panel | ClinGen:CA10584547 |
Duplication | NM_007294.4(BRCA1):c.5054_5057dup (p.Val1687fs) | BRCA1 | Pathogenic | 17 | 41219641 | 41219642 | A | ATGAG | reviewed by expert panel | ClinGen:CA10584549 |